News
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Realbotix CES 2025 Update
Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robots and companionship-based AI, successfully exhibited
Corient Acquires Multi-Family Office Business of Geller, Expanding U.S. Wealth Management Presence and Deepening Family Office Capabilities
Corient, one of the largest and fastest-growing national wealth advisors in the U.S., today announced it has acquired the multi-family office business of Geller & Company (“Geller MFO”). Geller MFO
GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Fuller, Smith & Turner PLC: Transaction in own shares
Median Technologies: Financial Communications Schedule for the First Half of 2025
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible), announces the publication date for its 2024 results:
Publication
Date
2024
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia
Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced positive results from an exploratory Phase 2A
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Learning through laughing with RiC.today from January 15 on simpliTV
Rand Capital Corporation Announces Shareholder Election Results for Fourth Quarter 2024 Stock and Cash Dividend
Rand Capital Corporation (Nasdaq: RAND) (“Rand” or the “Company”), a business development company providing alternative financing for lower middle market companies, announced today the results of
Fuller, Smith & Turner PLC: Transaction in own shares
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
EQS-Adhoc: infas Holding Aktiengesellschaft: infas Holding Aktiengesellschaft: Expansion of management board and expects changes in the supervisory board
EQS-News: Gold Terra: This is why a 3,000-meter drill hole is a good idea for a junior explorer
EQS-News: Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder
Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced enrollment of the first subject in a repeat dose
Ipsos beantragt gerichtlichen Ausschluss der Min-derheitsaktionäre gegen Barabfindung von EUR 6,80
CI Financial Announces Filing and Mailing of Circular for Special Meeting to Approve Plan of Arrangement with Mubadala Capital
CI Financial Corp. (“CI” or the “Corporation”) (TSX: CIX) today announced the commencement of the mailing of its management information circular and related shareholder meeting materials for the
Fuller, Smith & Turner PLC: Transaction in own shares